Chugai: Piasky (crovalimab) for Paroxysmal Nocturnal Hemoglobinuria approved in Japan

Dear Investor,Please find attached a press release by Chugai:https://www.roche.com/240326_Chugai_ePiasky_EN.pdfDo not hesitate to contact us for any further questions.With best regards,Roche Investor Relations Dr. Bruno EschliPhone: +41 61 68-75284e-mail:bruno.eschli@roche.com Dr. Sabine Borngr äberPhone: +41 61 68-88027e-mail:sabine.borngraeber@roche.com Dr. Birgit MasjostPhone: +41 61 68-84814e-mail:birgit.masjost@roche.com    Investor Relations North America Loren KalmPhone: +1 650 225 3217e-mail:kalm.loren@gene.com 
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news